Skip to main content
. 2021 Nov 1;8(1):35–41. doi: 10.1159/000520218

Table 3.

The total risk score accurately represents the complete patient prognosis

Total risk score 2 3 4 5 6
Patients, n (% of total) 41 (14) 109 (37) 61 (21) 54 (19) 26 (9)
Metastases, n (% of group) 0 (0) 2 (2) 5 (8) 15 (28) 11 (42)
3-Year K-M metastasis-free survival, % 100 98 88 62 39
(95% confidence interval) (100–100) (95–100) (78–100) (46–83) (20–76)